DUBLIN--(BUSINESS WIRE)--The 'Healthcare Market in India 2024-2029' report has been added to ResearchAndMarkets.com's offering.

都柏林--（商业新闻短讯）--“2024-2029年印度医疗保健市场”报告已添加到ResearchAndMarkets.com的产品中。

The healthcare market in India comprises companies offering healthcare services and related products, including hospitals, pharmaceuticals, medical equipment and supplies, diagnostic services, telemedicine, and medical insurance. In India, the healthcare industry is divided into primary, secondary, and tertiary healthcare tiers.

印度的医疗保健市场包括提供医疗保健服务和相关产品的公司，包括医院、药品、医疗设备和用品、诊断服务、远程医疗和医疗保险。。

These tiers of healthcare services are made available through a combination of public and private healthcare providers..

这些层次的医疗保健服务是通过公共和私人医疗保健提供者的组合提供的。。

Investments are being driven by the country's economic growth, business-friendly policies, and pharmaceuticals manufacturing landscape. The market is poised to grow on the back of specialized and higher quality healthcare facilities, increased incidence of lifestyle diseases, rapid health insurance penetration, and government initiatives..

投资受到该国经济增长、商业友好政策和制药制造业格局的推动。由于专业化和高质量的医疗保健设施、生活方式疾病发病率的增加、医疗保险的快速普及以及政府的举措，该市场有望增长。。

Market trends:

市场趋势：

With the growing number of medical colleges across India, regulating the quality of medical education is becoming increasingly important. The main emphasis is on enhancing the curriculum, faculty training, and accreditation processes to develop skilled and compassionate healthcare professionals. A key step forward is the government's recent mandate, starting in the 2024 - 25 academic session, requiring both government and private medical colleges to be evaluated by the Quality Council of India.

随着印度医学院校数量的不断增加，调节医学教育质量变得越来越重要。主要重点是加强课程，教师培训和认证过程，以培养技能和富有同情心的医疗保健专业人员。向前迈出的关键一步是政府最近的授权，从2024-25年的学术会议开始，要求政府和私立医学院都由印度质量委员会进行评估。

This initiative aims to ensure accountability, uphold high standards, and help students make informed decisions about their medical education..

这一举措旨在确保问责制，坚持高标准，并帮助学生就其医学教育做出明智的决定。。

Market drivers:

市场驱动因素：

India is transitioning from dealing primarily with communicable diseases to facing an increase in lifestyle-related illnesses. This shift has been driven by economic growth and urbanization, leading to a rise in demand for specialized healthcare services, diagnostics, and advanced medical devices. Increasing awareness about lifestyle diseases has also contributed to this trend, with people becoming more focused on healthy living and early detection.

印度正在从主要治疗传染病过渡到面临与生活方式有关的疾病增加。这种转变是由经济增长和城市化推动的，导致对专业医疗服务，诊断和先进医疗设备的需求增加。人们对生活方式疾病的认识不断提高也促成了这一趋势，人们越来越关注健康生活和早期发现。

According to the 2024 GOQii India Fit Report titled 'Thriving at Any Age: The Blueprint for Healthy Longevity', 45% of Indians are at risk of being unhealthy. The report identifies common lifestyle diseases such as diabetes, high blood pressure, high cholesterol, and thyroid disorders..

根据2024年GOQii India Fit题为“在任何年龄都茁壮成长：健康长寿的蓝图”的报告，45%的印度人有不健康的风险。该报告确定了常见的生活方式疾病，如糖尿病、高血压、高胆固醇和甲状腺疾病。。

Key deterrents to the growth of the market:

阻碍市场增长的关键因素：

Many hospitals in India, especially in rural regions, often lack the necessary infrastructure to support advanced clinical systems. Challenges like inconsistent electricity, limited internet access, and outdated facilities present major obstacles. As of 2023, the private sector had approximately 1,185,242 beds and the public sector had around 7,13,986 beds.

印度的许多医院，尤其是农村地区的医院，往往缺乏必要的基础设施来支持先进的临床系统。不稳定的电力、有限的互联网接入和过时的设施等挑战构成了主要障碍。截至2023年，私营部门约有1185242张床位，公共部门约有713986张床位。

This means the country has an average of less than 1.4 beds per 1,000 people, much lower than the WHO standard norm of 3.5 beds per 1000 people. Lack of adequate funding leading to poor infrastructure continues to be a major challenge for the players in the country..

这意味着该国平均每1000人拥有不到1.4张床位，远低于世卫组织每1000人拥有3.5张床位的标准。缺乏足够的资金导致基础设施薄弱，仍然是该国玩家面临的主要挑战。。

Key Topics Covered:

涵盖的关键主题：

Chapter 1: Executive Summary

第一章：执行摘要

Chapter 2: Socio-Economic Indicators

第2章：社会经济指标

Chapter 3: Introduction

第3章：简介

3.1. Market definition and structure

三点一。市场定义和结构

Chapter 4: Market Overview

第4章：市场概述

4.1. India Healthcare Market - An Overview

4.1条。印度医疗保健市场概述

4.2. Market Size and Growth Forecast Based on Value (FY 2022 - FY 2029e)

四点二。基于价值的市场规模和增长预测（2022财年至2029e财年）

4.3. Healthcare Landscape in Prominent States: An Overview (2024)

四点三。突出州的医疗保健前景：概述（2024年）

Chapter 5: Market Segmentation

第五章：市场细分

5.1. Pharmaceutical Market Segment - Market Size and Growth Forecast (FY 2022 - FY 2029e)

5.1条。制药市场细分-市场规模和增长预测（2022财年至2029e财年）

5.2. Hospital Segment - Market Size and Growth Forecast (FY 2022 - FY 2029e)

五点二。医院部门-市场规模和增长预测（2022财年至2029e财年）

5.3. Medical Equipment and Supplies Segment - Market Size and Growth Forecast (FY 2022 - FY 2029e)

五点三。医疗设备和用品细分市场-市场规模和增长预测（2022财年至2029e财年）

5.4. Diagnostic Services Segment - Market Size and Growth Forecast (FY 2022 - FY 2029e)

五点四。诊断服务部门-市场规模和增长预测（2022财年至2029e财年）

5.5. Telemedicine Segment - Market Size and Growth Forecast (FY 2022 - FY 2029e)

五点五。远程医疗细分市场-市场规模和增长预测（2022财年至2029e财年）

5.6. Medical Insurance Segment - Market Size and Growth Forecast (FY 2022 - FY 2029e)

五点六。医疗保险细分市场-市场规模和增长预测（2022财年至2029e财年）

Chapter 6: Market Influencers

第6章：市场影响者

6.1. Market drivers

六点一。市场驱动因素

6.2. Market challenges

六点二。

Chapter 7: Market Trends

第7章：市场趋势

Chapter 8: Recent Government Initiatives

第8章：最近的政府举措

8.1. Favorable Government initiatives

8.1条。有利的政府举措

Chapter 9: Competitive Landscape

第9章：竞争格局

9.1 Apollo Hospitals Enterprise Limited

9.1阿波罗医院企业有限公司

Company Information

公司信息

Business Description

业务描述

Products/Services

产品/服务

Key People

关键人物

Financial Snapshot

财务快照

Key Business Segments

关键业务部门

Key Geographical Segments

主要地理区域

9.2. Aster DM Healthcare Limited

九点二。Aster DM Healthcare Limited公司

9.3. Cipla Limited

9.3.Cipla有限公司

9.4. Dr. Lal PathLabs Limited

。Lal PathLabs博士有限公司

9.5. Fortis Healthcare Limited

9.5.富通医疗保健有限公司

9.6. Healthcare Global Enterprises Limited

九点六。

9.7. Narayana Hrudayalaya Limited

9.7.Narayana Hrudayalaya有限公司

9.8. Sun Pharmaceuticals Industries Limited

九点八。太阳制药工业有限公司

9.9. Columbia Asia Hospitals Private Limited

九点九。哥伦比亚亚洲医院私人有限公司

9.10. Max Healthcare Private Limited

9.10条。Max Healthcare私人有限公司

Chapter 10: Recent Developments

第10章：最新发展

10.1. Research methodology

10.1条。研究方法论

Chapter 11: Appendix

第11章：附录

For more information about this report visit https://www.researchandmarkets.com/r/jcqs53

有关此报告的更多信息，请访问https://www.researchandmarkets.com/r/jcqs53

About ResearchAndMarkets.com

关于ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com是全球领先的国际市场研究报告和市场数据来源。我们为您提供有关国际和地区市场、关键行业、顶尖公司、新产品和最新趋势的最新数据。